The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Clinical trial NCT01757431 · COMPLETED
Trial details
- NCT number
- NCT01757431
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-16
- Primary completion
- 2013-09-24
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.